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Background: Several studies have reported lower perioperative complications with unicompartmental
knee arthroplasty (UKA) than with total knee arthroplasty (TKA). However, there is a paucity of data
analyzing the incidence of periprosthetic joint infection (PJI) in similar patients undergoing UKA and
TKA. As such, we sought to analyze the incidence of UKA and TKA PJI in a large matched population.
Material and Methods: The Mariner data set of the PearlDiver database was queried for all patients
undergoing UKA or TKA during 2010-2017. Included patients were required to have at least 2 years of
database inclusion after surgery. Patients were then matched at a 1:3 ratio (UKA:TKA) on age, gender,
Elixhauser Comorbidity Index, tobacco use, and obesity. Rates of PJI requiring operative intervention
within 90 days and 1 year were calculated.
Results: In total, 5636 patients having undergone UKA were matched to 16,890 patients having undergone TKA. Fifteen (0.27%) after UKA and 79 (0.47%) after TKA had a PJI surgically managed within 90 days
(risk ratio ¼ 0.57, 95% conﬁdence interval ¼ 0.33-0.99, P ¼ .04). Thirty (0.53%) after UKA and 136 (0.81%)
after TKA had a PJI surgically managed within 1 year (risk ratio ¼ 0.66, 95% conﬁdence interval ¼ 0.450.98, P ¼ .04).
Conclusions: In a large group of rigorously matched patients, UKA was associated with a signiﬁcantly
lower rate of surgically managed PJI than TKA at 90 days and 1 year; however, the rate of PJI in both
groups remained low at <1% at 90 days and 1 year.
© 2021 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Introduction
Unicompartmental knee arthroplasty (UKA) remains a successful surgery to relieve pain and improve function in select patients with isolated compartment pathology [1-4]. While
traditionally the criteria for UKA were strict [5], the indications and
criteria have expanded [2,6-9], and the incidence of UKA has
increased over the past decade [10,11]. Furthermore, the introduction of robotic and computer-assisted techniques has been
shown to improve UKA alignment, component position, and
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potentially functional outcomes and revision rates [12-14]; as such,
the wider adoption of robotic-assisted UKA may further increase
the incidence of UKA [14,15].
While the long-term revision rates of UKA are higher than those
of total knee arthroplasty (TKA) in most series in the literature
[4,16-18], there are several reported advantages of a UKA compared
with TKA. These include improvement in functional outcomes,
higher activity level, quicker recovery, less pain and narcotic requirements postoperatively, and lower short-term complications
[17-24]. Furthermore, UKA has been touted to have a lower rate of
deep periprosthetic joint infection (PJI) than TKAs, although recent
data show that treatment of UKA PJIs does not have better outcomes than TKA PJI treatment [25,26]. However, owing to the low
incidence of UKA compared with TKA [10,11], the relatively low
incidence of deep PJI in both UKA and TKA, and selection bias of
younger and healthier patients toward UKA [15-27], there is a

https://doi.org/10.1016/j.artd.2021.06.006
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paucity of adequately powered data comparing UKA and TKA PJI
rates in similar patient populations.
As such, the goal of the present study was to compare the
incidence of reoperation for deep PJI at 90 days and 1 year in a large
sample of patients from an administrative claims database undergoing UKA to a matched cohort of similar patients undergoing TKA.
In addition, we sought to analyze how UKA PJIs were treated at both
90 days and 1 year. We hypothesize that the rate of surgically
treated PJI at 90 days and 1 year will be lower for UKA than that for
TKA.
Material and methods
Data source
The Mariner data set of the PearlDiver research database
(PearlDiver Technologies, Colorado Springs, CO) was used to query
deidentiﬁed, administrative claims data from patients covered by
private insurance, Medicare Advantage, Medicaid, and/or claims
paid with cash. It includes roughly 122 million total patients and
spans the years of 2010 to 2018. The present study used Common
Procedural Terminology (CPT), International Classiﬁcation of Diseases (ICD)-9 and ICD-10 diagnosis and procedural codes included
within the data set (Appendix). The data within this database are
Health Insurance Portability and Accountability Act compliant and
deemed exempt from institutional review board review.
Patient selection and outcomes
Patients who underwent UKA and primary TKA were identiﬁed
using codes CPT-27,446 and CPT-27,447, respectively, to preliminarily create 2 cohorts (Fig. 1). All patients were limited to analysis
of their ﬁrst UKA or TKA if they underwent more than one UKA or

TKA in the database. Patients who were included in both groups,
with an index procedural code for TKA occurring after index UKA,
were included in the UKA cohort and eliminated from the TKA
cohort so that the patient could not be matched to himself/herself.
Patients were then limited to only those who had continuous
database inclusion for at least 2 years. In order to minimize potential bias in patient selection criteria, patients with morbid
obesity (body mass index [BMI] > 40 kg.m2) were excluded as many
surgeons consider morbid obesity a contraindication for UKA. Patients in each cohort were then matched on a patient to patient
basis in a 1:3 ratio (UKA:TKA) on age, sex, Elixhauser Comorbidity
Index, obesity (BMI > 30 kg/m2), and tobacco use, and ﬁnal demographic information was reported for each matched cohort
(Table 1). Outcome of infection within 90 days and 1 year of index
procedure was reported for each cohort using ICD-9 and ICD-10
diagnosis codes for PJI (Table 2). In addition, the treatment modality used to address PJI in the UKA cohort was reported by
stratiﬁcation into explantation or treatment with debridement,
antibiotics, and implant retention (DAIR) using CPT, ICD-9, and ICD10 procedural codes (Table 2). Diagnosis codes of PJI had to be
linked to the same record as the procedural code identiﬁed as the
mode of treatment.
Statistical analysis
Descriptive statistics were used to describe the demographic
and clinical characteristics of the matched groups. Descriptive
statistics were also used to present the rates of PJI at both 90 days
and 1 year in the UKA and TKA groups. The association between
surgical type and PJI at both 90 days and 1 year was expressed using
the relative risk of PJI in the UKA group compared with the TKA
group with 95% conﬁdence intervals (C.I.) used to assess the statistical signiﬁcance of this association. Even though there was

Figure 1. Flowchart representing the total number of patients in the database and those excluded due to inadequate follow-up or exclusion criteria. ECI, Elixhauser comorbidity
index.
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Table 1
Characteristics of matched UKA and TKA patients.
UKA, N ¼ 5636

Characteristic
Sex
Male
Female
Age
30-39
40-49
50-59
60-69
70-79
ECI
Mean ± SD
Tobacco use
Yes
No
Obesity
Yes
No
Service location
Hospital inpatient
Hospital outpatient

TKA, N ¼ 16,890

2670 (47.4%)
2966 (52.6%)

7993 (47.3%)
8897 (52.7%)

20
357
1488
1929
1842

51
1063
4463
5786
5527

(0.4%)
(6.3%)
(26.4%)
(34.2%)
(32.7%)

(0.3%)
(6.3%)
(26.4%)
(34.3%)
(32.7%)

4.84 ± 3.23

4.84 ± 3.22

1090 (19.3%)
4546 (80.7%)

3259 (19.3%)
13,631 (80.7%)

1574 (27.9%)
4062 (72.1%)

4711 (27.9%)
12,179 (72.1%)

3442 (61.1%)
2194 (38.9%)

16,307 (96.5%)
583 (3.5%)

ECI, Elixhauser comorbidity index.

dependency structure within the data created by matching, this
could not be incorporated into the statistical analysis given the
manner in which data are output from the PearlDiver platform. We
elected to match 1:3 UKAs to TKAs given the rarity of UKA PJIs and
the signiﬁcantly higher number of TKAs in the database. Descriptive statistics were also used to describe the treatment characteristics of UKA patients with PJI. No adjustment was made for
multiple hypothesis testing, and an alpha threshold of 0.05 was
used to assess the statistical signiﬁcance of associations as reﬂected
by the 95% level for the C.I. All analyses were performed using Stata
16.1 (StataCorp, College Station, TX).

Results
Patient matching and demographics
In total, 5636 patients having undergone UKA were matched to
16,890 patients having undergone TKA (Table 1). As would be expected based on matching, the groups were evenly matched based
on demographic and clinical characteristics but not by service
location, which was not included in matching. Patients undergoing
UKA were more frequently treated as outpatient.

Incidence of PJI in UKA and TKA
Of patients undergoing UKA, 15 (0.27%) had a PJI surgically
managed within 90 days (Table 2). Of patients undergoing TKA, 79
(0.47%) had a PJI surgically managed within 90 days. UKA was
associated with a signiﬁcantly lower risk of PJI within 90 days with
a risk ratio of 0.57 and 95% C.I. from 0.33 to 0.99 (P ¼ .04).
Table 2
Association of UKA compared to TKA with infection.
UKA, N ¼ 5636
PJI in 90 d
N (%)
RR (95% C.I.)
PJI in 1 y
N (%)
RR (95% C.I.)
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Of patients undergoing UKA, 30 (0.53%) had a PJI surgically
managed within 1 year. Of patients undergoing TKA, 136 (0.81%)
had a PJI surgically managed within 1 year. UKA was associated
with a statistically signiﬁcant lower risk of PJI within 1 year, with a
risk ratio of 0.66 and 95% CI from 0.45 to 0.98 (P ¼ .04).
UKA PJI treatment
Of the 15 patients who underwent surgical management of their
UKA infection within 90 days, 10 (67%) initially underwent a DAIR.
Of the 15 patients who underwent surgical management of their
UKA between 91 days and 1 year of UKA, 6 (40%) initially underwent a DAIR (Table 3).
Discussion
The overall incidence of UKA is steadily increasing and expected
to continue to increase in the next decade [6-11], especially with
the introduction of computer navigated and robotic techniques [1215]. Numerous studies have reported lower perioperative and
short-term complications of UKA compared to TKA [4,17-24]. The
low incidence of UKA compared to TKA and biased selection of
younger and potentially healthier patients for UKA over TKA render
such comparisons, especially for complications with a low incidence such as PJI, and lead to studies being often underpowered
and biased. As such, we sought to rigorously match patients undergoing UKA to those undergoing TKA in a large non-Medicare
population to compare the incidence of PJI in each cohort. We
found that UKA conferred a signiﬁcantly lower rate of PJI than TKA
at 90 days (RR ¼ 0.57) and 1 year (RR ¼ 0.66).
Several studies have reported lower perioperative complication
rates of UKA, including lower medical complication rates [4,18],
reduced rates of venous thromboembolism [4,18], lower readmission rates [4,18], as well as decreased LOS, lower opioid requirements, and improved functional outcomes [17,19,22]
compared with TKA. However, no studies to the authors’ knowledge directly compare the incidence of UKA and TKA PJI in the US
population. Reported rates of UKA and TKA PJI vary signiﬁcantly
depending on the institution and patient population, ranging from
0% to 2.5% [4,18-23,27,28e30] at early time points. Lum et al. [29]
reported a 0% UKA PJI rate in 650 patients with a BMI > 35 kg/m2 at
a mean follow-up of 2.3 years; conversely, Nettrour et al. [28] reported a 2.2% rate of UKA PJI in patients with a BMI > 40 kg/m2 at a
mean follow-up of 3.4 years. While the reported rates of PJI vary,
most US cohort studies report the rate of UKA PJI from 0.5% to 1%
[4,27,28e30].
While there have been very few studies comparing UKA and
TKA PJI rates in the United States, a few studies of European patient populations have directly or indirectly compared their rates.
In a 1:3 matched cohort of 101,330 patients undergoing 25,334
UKAs and 75,996 TKAs in the National Joint Registry for England
and Wales analyzing adverse outcomes as a whole, Liddle et al.
[18] found a 2-fold increased risk of revision for UKA at 8 years but

Table 3
Surgical management of infection for UKA.
TKA, N ¼ 16,890

15 (0.27%)
0.57 (0.33-0.99)

79 (0.47%)
0.00 (Ref)

30 (0.53%)
0.66 (0.45-0.98)

136 (0.81%)
0.00 (Ref)

UKA, N ¼ 5636
PJI in 90 d
Explant
DAIR
PJI at 91 d to 1 y
Explant
DAIR

5 (33%)
10 (67%)
6 (40%)
9 (60%)
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signiﬁcantly reduced perioperative complications, length of stay,
and rate of readmission. While not a major outcome measure, they
did also ﬁnd that the incidence of PJI in UKA was signiﬁcantly
lower than that in TKA (HR ¼ 0.5, P < .001) and accounted for just
~5% of all revision UKAs compared with 25% of all revision TKAs
[18]. In an unmatched observational cohort study of 679,010 knee
arthroplasties from the England and Wales registry, Poisson and
piecewise exponential multilevel regression models used to
analyze several risk factors for PJI; cemented UKA also conferred a
lower rate of PJI (RR ¼ 0.5) compared to cemented TKA [23].
Finally, in an older study of roughly 5000 knee arthroplasties in
the Norwegian registry performed between 1994 and 2004, the
overall risk of revision was 2-fold higher for UKA than that for
TKA, but UKAs were associated with a lower (RR ¼ 0.28, P ¼ .01)
risk of PJI than TKA [31]. The results of these registry-based studies
are similar to those of the present study, in which UKA conferred a
lower risk of PJI in a matched patient cohort at 90 days and 1 year.
As expected, most UKA PJIs in the present study within 90 days
were treated with a DAIR (67%), while 60% of UKA PJIs treated
beyond 90 days were treated with a DAIR. Recent studies have
shown that DAIR has equally poor, if not worse, outcomes for UKA
than for TKA, even in relatively young and healthy patient populations. In the largest study on UKA PJI treatment outcomes, DAIR
for acute postoperative PJI had a survivorship free from all-cause
reoperation of 55% at 2 years, including a 31% failure for PJI [25].
Similarly, Hernandez et al. [26] reported that 6 of 11 (55%) patients
with UKA PJI treated with DAIR underwent septic (n ¼ 4) or
aseptic (m ¼ 2) reoperation by 5 years. In comparison, Weston
et al [32] reported a 33% rate of reinfection within 5 years in patients with acute postoperative TKA PJIs treated with DAIR. As
such, while UKA may be associated with slightly lower rates of
deep PJI, the outcomes of PJI treatment do not appear to be superior to those of TKA; however, there is a paucity of data on their
outcomes.
We acknowledge several limitations to the present study. First, it
is a large database study with inherent limitations and biases.
However, given the lower incidence of UKA and even lower incidence of UKA PJI, with less than 50 UKA PJIs speciﬁcally analyzed in
the literature [25,26], a large database study is likely the most
resource-efﬁcient method to address this question. Furthermore,
while databases rely on accurate coding of procedures and diagnoses, the main goal of this study was to compare UKA and TKA
PJI, so the potential of PJI being miscoded should not bias this association differently in one group more than the other. Furthermore, it is possible despite matching on several key demographics
that the study populations were not equivalent and that patient
selection bias on other nonmatched factors may have occurred.
Finally, we did not analyze risk factors for UKA PJI as the overall
number of patients who developed a UKA PJI, even in this large
database sample, was low.

Conclusions
In this large non-Medicare population study of rigorously
matched cohorts of patients undergoing either UKA or TKA, UKA
conferred a signiﬁcantly lower risk of PJI at 90 days (RR ¼ 0.57) and
1 year (RR ¼ 0.66) than TKA. However, the overall incidence of PJI in
both UKA and TKA patients at 90 days and 1 year was overall low at
<1%. As such, surgeons should continue to balance the short-term
beneﬁts and lower perioperative complications of UKA for patients compared to the improved long-term durability of TKA when
counseling patients on knee arthroplasty options.
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Appendix

Supplementary Table 1
Codes used.
Description

Codes used

Unicompartmental arthroplasty
Total knee arthroplasty
Periprosthetic joint infection

CPT-27446
CPT-27447
ICD-9-D-99669, ICD-10-D-T8450XA, ICD-10-D-T8450XD, ICD-10-D-T8450XS, ICD-10-D-T8459XA, ICD-10D-T8459XD, ICD-10-D-T8459XS, ICD-10-D-T8453XA, ICD-10-D-T8453XD, ICD-10-D-T8453XS, ICD-10-DT8454XA, ICD-10-D-T8454XD, ICD-10-D-T8454XS, ICD-9-D-99660, ICD-9-D-99666, ICD-9-D-99667
CPT-27486, CPT-27487, CPT-27488, ICD-9-P-0080, ICD-9-P-0081, ICD-9-P-0082, ICD-9-P-0083, ICD-9-P8006, ICD-9-P-8155, ICD-10-P-0SPC0JC, ICD-10-P-0SPC0JZ, ICD-10-P-0SPD0JC, ICD-10-P-0SPD0JZ, ICD-10P-0SPT0JZ, ICD-10-P-0SPU0JZ, ICD-10-P-0SPV0JZ, ICD-10-P-0SPW0JZ, ICD-10-P-0SWC0JC, ICD-10-P0SWC0JZ, ICD-10-P-0SWD0JC, ICD-10-P-0SWD0JZ, ICD-10-P-0SWT0JZ, ICD-10-P-0SWU0JZ, ICD-10-P0SWV0JZ, ICD-10-P-0SWW0JZ
CPT-27486, CPT-27487, CPT-27488, ICD-9-P-0080, ICD-9-P-0081, ICD-9-P-0082, ICD-9-P-0083, ICD-9-P8006, ICD-9-P-8155, ICD-10-P-0SPC0JC, ICD-10-P-0SPC0JZ, ICD-10-P-0SPD0JC, ICD-10-P-0SPD0JZ, ICD-10P-0SPT0JZ, ICD-10-P-0SPU0JZ, ICD-10-P-0SPV0JZ, ICD-10-P-0SPW0JZ, ICD-10-P-0SWC0JC, ICD-10-P0SWC0JZ, ICD-10-P-0SWD0JC, ICD-10-P-0SWD0JZ, ICD-10-P-0SWT0JZ, ICD-10-P-0SWU0JZ, ICD-10-P0SWV0JZ, ICD-10-P-0SWW0JZ

Explantation

Debridement, antibiotics, and implant retention

